Call for Abstract

5th International Conference on Diabetes and Endocrinology, will be organized around the theme “Challenging & Opportunities to Bridge the Flaws in Diabetic Healthcare ”

Clinical-Endocrinology 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Clinical-Endocrinology 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

 Diabetes is traditionally viewed as a chronic and relentless disease in which delay of end-organ complications is the major goal in treatment, bariatric surgery offers a novel endpoint: complete disease remission or major improvement.

 

Bariatric surgeries constitute a powerful option to ameliorate diabetes in patients affected by obesity severely. Bariatric surgery is an appropriate treatment for people with Type 2 Diabetes and obesity not achieving recommended treatment targets with other medical therapies and also very cost - effective.

 

  • Track 1-1Diabetes Surgery: A New Discipline
  • Track 1-2Diabetes and Bariatric Surgery
  • Track 1-3Diabetes and Metabolic surgeries
  • Track 1-4Diabetes and Sleeve gastrectomy
  • Track 1-5Diabetes and Heart / Vascular Surgery
  • Track 1-6Diabetes organ transplantation / organ removal surgery
  • Track 1-7The Risks and complications of Surgery for Diabetics
  • Track 1-8Diabetes Surgery: Opportunities, Barriers, and Limitations

 The artificial pancreas bridges of diabetes technology that already exist: the insulin pump and the continuous glucose monitor (CGM). A large percentage of world population is affected by diabetes mellitus, out of which approximately 5-10% with type 1 diabetes while the remaining 90% with type 2 diabetes. Insulin administration is essential for the patients of type 2.

Present insulin delivery systems are available as transdermal injections. Several approaches for insulin delivery are being pursued by pharmaceutical companies to reduce the pain, and hypoglycemic incidences associated with injections.

 

  • Track 2-1Informatics in the service of medicine; telemedicine, software and other technologies
  • Track 2-2Blood glucose monitoring: Glucose pumps and sensors
  • Track 2-3Insulin pumps and insulin infusion systems
  • Track 2-4Insulin secretion in vitro and exocytosis
  • Track 2-5Insulin Pens and novel Insulin delivery techniques
  • Track 2-6Acupuncture for diabetic complications
  • Track 2-7Glucose sensors (invasive and non-invasive)
  • Track 2-8Closed-loop system and algorithm

\r\n Anti-Diabetic Medications work by two mechanisms either lowering blood glucose level or by increasing sensitivity to insulin. People can self-inject insulin under the skin if hospitalized a doctor/nurse might inject insulin directly into the blood. 

\r\n

\r\n There are several different types of insulin-like Rapid-acting injections that take less time to show effect i.e within 5 to 15 minutes but lasts for a shorter time period of 3 to 5 hours, Short-acting injections take 30 minutes and 1 hour  time to show effect and last for 6 to 8 hours. Intermediate-acting injections that take about 1 to 4 hours to show effect and it last for 10 to 26 hours, Long-acting injections show effect after 1 or 2 hours and it last for between 14 and 24 hours.

\r\n

\r\n Other than insulin there are many other oral antidiabetic medications which are non-insulin injectables in the market. They include Biguanides, Sulphonylureas, Meglitinides, Thiazolidinediones, Alpha-Glucosidase Inhibitors,  Gestational diabetes.

\r\n

\r\n  

\r\n

  • Track 3-1Neonatal diabetes
  • Track 3-2Pediatric diabetes
  • Track 3-3Factors considered in selecting proper medications
  • Track 3-4Bio availability and bio equivalence of drugs in diabetic patients

Diabetic drugs have the highest market shares amongst drugs and devices compared to other and are also expected to have the highest rate in growth with a CAGR of 8.9%. Diabetic drugs are highly priced it would be one of the major drawbacks.

Diabetic devices include insulin delivery devices and blood glucose meters. The market for blood glucose meters is having the top market shares compared to the insulin delivery systems such as syringes and injection pens. Meter and strips are one of the most expected to dominate the overall market share in diabetic devices

  • Track 4-1Global Demographics & Market Dynamics
  • Track 4-2Comprehensive research methodology of Diabetes market
  • Track 4-3Analysis of regional regulations
  • Track 4-4Insights about market determinants
  • Track 4-5Global Challenges and Unmet Needs
  • Track 4-6Comprehensive research methodology of Diabetes market

Additional fat in the body may have destructive impacts, such as producing hormones and development factors can influence the way our cells work. Fat cells can also attract immune cells to body tissues which release chemicals that cause a long-term inflammation. Individuals with obesity have chronic low-level or subacute unresolved inflammations, which is related to expanded malignancy chance.

Gestational diabetes cause problems for your baby and you during pregnancy and after birth. But the risks can be reduced if the condition is detected early and well managed.Gestational diabetes is high blood sugar (glucose) that develops during pregnancy. It happens when your body cannot produce enough insulin – a hormone that helps control blood sugar levels – to meet your extra needs in pregnancy.

  • Track 5-1Genetic Linkage
  • Track 5-2Medication for Diabetes and Cancer
  • Track 5-3Diagnosis
  • Track 5-4Case Studies
  • Track 5-5Obesity and Reproductive Function

 Biosimilars are biological medical products/molecules which are almost identical copies of an original product manufactured by different companies and an already FDA-approved biological product, referred to as a reference product.  Human bio monitoring (HBM) is a tool of health-related environmental monitoring.

 

 Diabetes is a major lifestyle disease, It is necessary to identify potential biomarkers associated with diabetes for early detection and proper management of diabetes.  Biomarkers are known as signature molecules or molecular markers or biological molecules found in blood, tissues and other body fluids. Biomarkers are used to monitor how well the body is responding to a particular disease. Hemoglobin A1c is considered as a biomarker for the presence of Diabetes Mellitus biosimilars in diabetes.

 

  • Track 6-1Scope and Role of Biomarkers
  • Track 6-2Biomarker Application in diabetes research
  • Track 6-3Novel Biomarkers
  • Track 6-4Biosimilar Development, Review, and Approval
  • Track 6-5Biosimilar and Interchangeable Products
  • Track 6-6Biosimilar and Interchangeable Products
  • Track 6-7Prescribing Biosimilar and Interchangeable Products
  • Track 6-8Biosimilar Product Information

 Diabetes Mellitus is a chronic condition with abnormally high levels of sugar in the blood. Insulin is produced by the pancreas then it lowers blood glucose. During, Absence or insufficient production of insulin, or an inability of the body to properly use insulin causes diabetes.

 Diabetes causes vary depending on our genetic makeup, family history, ethnicity, health and environmental factors. Type 1 diabetes is an autoimmune condition which means that the immune system mistakenly attacks and destroys the beta cells in the pancreas that then produce insulin. Type 2 diabetes starts as insulin resistance. It means that the body cannot use insulin efficiently which stimulates your pancreas to produce more insulin. Gestational diabetes is also due to insulin-blocking hormones produced during pregnancy.

 

  • Track 7-1Type 1 diabetes
  • Track 7-2Type 2 diabetes
  • Track 7-3Pre-diabetes
  • Track 7-4Gestational diabetes

 Diabetes is a serious issue which is still uncured and makes new research, in treatment and management techniques is a crucial necessity. Over the past years, there have been considerable breakthroughs in preventing diabetic complications by understanding them.

 

Nanotechnology in diabetes is the advancement of novel glucose estimation and insulin conveyance modalities that hold the possibility to drastically enhance the personal satisfaction for diabetics. Nano-medication is typically 10-100 times littler than a body's phone yet just minimal bigger than particles makes conceivable the treatment of the starting point of diabetes at the atomic level.

 

  • Track 8-1Nanotechnology in diabetes
  • Track 8-2Human Recombinant Insulin
  • Track 8-3Digital Healthcare: Designing the Digital Solution
  • Track 8-4Blood Glucose Monitoring and Glycemic Control in the Hospitals
  • Track 8-5Computerised applications in Diabetes mitigations
  • Track 8-6Informatics in the Service of Medicine, Telehealth, Telemedicine, Software and other Technologies
  • Track 8-7Clinical Decision Support Systems/Advisors
  • Track 8-8Securing funding for diabetes technology

 Health education is a combination of learning experiences designed to help individuals or communities improve their health, by increasing their knowledge or influencing their attitudes, by focusing on prevention. Diabetes education will reduce the costs that individuals, families, insurance companies, medical facilities, communities, the state, and the nation would spend on medical treatment.

 

Health promotion is the process of enabling people to increase control over and to improve their health, it moves beyond a focus on individual behavior towards the wide range of environmental and social interventions.

 

  • Track 9-1Public Awareness Campaigns
  • Track 9-2Promotional Initiatives – Webinars, Books & Publications

 Most common medical devices used in diabetes diagnosis and treatment include blood-glucose meters, insulin pens, insulin pumps. These devices include glucose ministering devices, Bioartificial pancreas, insulin delivery systems, and insulin administrating systems. And many diabetes monitoring and diagnostic devices like lancets, analog glucose monitor, test Strips, Syringe, Injectors also come under this. And these devices are designed to be feasible to use and painless in the insertion. Some companies are joining up and put their efforts to create a contact lens that measures the glucose in tears

 

  • Track 10-1Insulin Pens and novel Insulin delivery techniques
  • Track 10-2Closed-loop system and algorithm
  • Track 10-3Flash Glucose Monitoring.
  • Track 10-4Insulin dose calculation software
  • Track 10-5Intravenous blood glucose monitoring systems
  • Track 10-6Blood glucose monitoring: Glucose pumps & sensors
  • Track 10-7New Insulin Analogues
  • Track 10-8Artificial pancreas
  • Track 10-9The future: the Artificial Beta Cell
  • Track 10-10Continuous glucose monitoring (CGM)/ Blood Glucose Meters
  • Track 10-11Tear glucose monitoring contact lenses
  • Track 10-12New insulin delivery systems: Inhaled, transdermal patches, and implanted devices

Excess amounts of sugars or glucose in the blood lead to such a chronic condition called diabetes mellitus. High glucose in blood may cause eye damage, kidney damage, and nerve damage. Diabetes increases the risk of different cardiovascular diseases, such as coronary heart disease, heart attack, heart stroke and narrowing of arteries which diminishes the blood move through the arteries.

The abnormal rise of glucose in the blood can harm veins and nerves of the eye, which leads to loss of visions.Diabetes is the main cause of cardiovascular diseases, kidney diseases and loss of vision.

 

  • Track 11-1Diabetic cardiomyopathy
  • Track 11-2Diabetic Nephropathy
  • Track 11-3Diabetic Neuropathy
  • Track 11-4Diabetic Retinopathy
  • Track 11-5Diabetes Dermatology
  • Track 11-6Diabetes Pediatrics
  • Track 11-7Diabetes and Oral health
  • Track 11-8Diabetes and Colo-Rectal Cancer

 Diabetes Management mainly aims to minimize the risk of long-term consequences associated with diabetes. It not only involves keeping a check on blood glucose,  blood pressure, and cholesterol levels but also focussing on modern approaches like exercise, diet and lifestyle management often coupled with on-going blood glucose level monitoring.  Self-management of diabetes is also another crucial thing for proper adherence to dietary and lifestyle modifications.

 

 Regular check-ups on cholesterol, blood pressure, HDL, LDL & triglyceride levels, and eye examination to prevent diabetic retinopathy, foot care specialist is to prevent diabetes occurrence. And the other complications caused due to other diseases such are obesity, cancer are to be treated or prevented.

 

 

  • Track 12-1Diabetic Diet Management- Food, micronutrients
  • Track 12-2Management of Neuro Diabetes
  • Track 12-3Management of Diabetic Foot Diseases
  • Track 12-4Management of Diabetic Kidney Diseases
  • Track 12-5Management of Diabetic Eye Diseases
  • Track 12-6Management of Diabetic Cardiovascular Diseases
  • Track 12-7Management of Diabetes hypertension / blood pressure
  • Track 12-8Management of Gestational Diabetes / Menstruation and menopause (Diabetic women)
  • Track 12-9Management of Neonatal and Pediatric diabetes
  • Track 12-10Clinical care management of Diabetes - Medication
  • Track 12-11Diabetic Diet Management- Food, micronutrients
  • Track 12-12Management of Diabetes obesity

Pharmacoeconomic  research is the process of identifying, measuring and comparing the costs, risks and benefit of services, therapies and determining which alternatives can produce the best health outcomes for resource invested.  Diabetes mellitus patients require frequent monitoring of blood glucose levels, anti-diabetic drugs on a chronic basis and all of which result in a significant economic burden on the diabetes patients and the world economies.

 

 Diabetes  with complications results in double the cost when compared to diabetes alone, so that the burden of diabetes and its complications was significant for an individual. This cost associated with the disease is preventable by diet restriction and aerobic exercise, to reduce the prevalence of diabetes and its complications in mind.

 

  • Track 13-1Pharmacoeconomic challenges in the management of diabetes
  • Track 13-2Humanistic Evaluation Methods
  • Track 13-3Pharmacoeconomic Controversy
  • Track 13-4Pharmacoeconomic Consequences
  • Track 13-5Drug Therapy EvaluationDrug Therapy Evaluation
  • Track 13-6Naturalistic pharmacoeconomic studies
  • Track 13-7Strategies to Incorporate Pharmacoeconomics into Pharmacotherapy
  • Track 13-8Pharmacoeconomic challenges in the management of diabetes
  • Track 13-9Methods of Pharmacoeconomics

Pediatric Endocrinology is a medicinal sub-specialty managing the development issue and sexual differentiation in children. Additionally, it is associated with neonatal diabetes and the different issue of the endocrine organs. Pediatric Endocrinology incorporates the investigation of type 1 and type 2 diabetes in the infants.

The Division of Pediatric Cardiology oversees the analysis of congenital heart defects, performing the diagnostic procedure such as echocardiograms, cardiac catheterizations, and electrophysiology. There are additionally other pericardial diseases that can introduce clinically as acute pericarditis, pericardial effusion, heart tamponade, and constrictive pericarditis.

 

  • Track 14-1Disease associated with Pediatric Endocrinology
  • Track 14-2Pediatric Cardiology
  • Track 14-3Disease associated with Pediatric Endocrinology Cardiology

Diabetes research takes many forms throughout the world. Diabetes research is a global task. In this review, we explore what an ideal diabetes therapy would look like from the perspective of several key in diabetes drug development. Increased diabetes was the leading cause of blindness, kidney failure, and non-traumatic lower-limb amputations.

 

Diabetes therapies are described by their brand names to differentiate new therapies with generic names similar to those of existing therapies and to draw distinctions between separate therapies that share the same generic names.

 

  • Track 15-1Anatomy of Endocrine system
  • Track 15-2Endocrine Tissues and Organs
  • Track 15-3Role of DNA methylation in insulin secretion
  • Track 15-4Intravenous blood glucose monitoring systems
  • Track 15-5Insulin dose calculation software
  • Track 15-6Flash Glucose Monitoring
  • Track 15-7Closed-loop system and algorithm

The importance of the psychological state consultants in the management of medically ill individuals has grown with the proliferation of information linking health and behavior.

 

 People with diabetes experience disproportionately high rates of mental health issues such as anxiety, depression and eating disorders. Most of the studies state that people with diabetes must have access to psychological treatment and support in order to reduce psychological distress and improve self-management.

 

  • Track 16-1Diabetes Psychological care
  • Track 16-2Role of the Psychologist in Diabetes
  • Track 16-3Psychosocial Factors in Diabetes Care : emotional factors, social factors, behavioral factors
  • Track 16-4Psychopathology in Diabetes
  • Track 16-5Emotional and psychological needs for diabetic individuals.
  • Track 16-6Psychosocial Issues Unique to Children and Adolescents

Genomic studies have greatly advanced our understanding of the multifactorial aetiology of diabetes especially in type 2 diabetes (Diabetes Mellitus) as well as the multiple subtypes of monogenic diabetes mellitus. These studies focus on a few feasible candidate genes involved in drug pharmacodynamics / pharmacokinetics, or those associated with Type 2 diabetes as a disease phenotype.Here in relation to diabetes the main focus is on mostly used drugs in diabetes treatment such as sulfonylureas, metformin and thiazolidinediones (troglitazone, pioglitazone, and rosiglitazone).

 

  • Track 17-1Genomics
  • Track 17-2Toxgnostics
  • Track 17-3Population groups in biomedicine
  • Track 17-4Pharmacovigilance
  • Track 17-5Metabolomics
  • Track 17-6Toxicogenomics
  • Track 17-7Genetic engineering
  • Track 17-8Clinomics
  • Track 17-9Chemogenomics
  • Track 17-10Medical terminology

Eating Disorder is basically portrayed by abnormal consumption of food which contrarily influences a man's psychological and physical health. This dysfunctional behavior has six broad types which incorporate binge eating disorder, anorexia nervosa, bulimia nervosa, rumination disorder, restrictive food intake disorder and other specified feeding or eating disorder.

This Psychiatric Disorder creates a bad impact on the body weight of a person. Anorexia nervosa is generally regular among young ladies with a risk group of 15-19-year-old young girls. Very nearly half of individuals with eating disorders meet the criteria for depression. Both hereditary and ecological factor plays a role in Eating Disorder. Treatment incorporates Counselling, appropriate eating diet, and medication.

 

  • Track 18-1Diagnostic Methods
  • Track 18-2Pathophysiology of Eating Disorder
  • Track 18-3Personality Traits
  • Track 18-4Compulsive Overeating
  • Track 18-5Case Studies and Risk Factor

Nutrition & Metabolism centers around the coordination of sustenance, practice physiology, clinical examinations, and atomic and cell natural chemistry of digestion. Metabolic impacts of dietary protein are unpredictable

The dietary prerequisites of a neonate are fundamentally more noteworthy than those of a grown-up in light of the fact that not exclusively are there necessities for substrate admission

  • Track 19-1Response to ingested Glycine
  • Track 19-2Metabolic response to Hypoxia

Heart Diseases describes a range of conditions that influence your heart. Disease under the coronary illness umbrella incorporates blood vessel diseases. For example, coronary artery disease; heart rhythm problems (arrhythmias), congenital heart defects, Rheumatic heart disease, Hypertensive heart disease, Ischemic heart disease, Hypertension.

Heart failure is a condition in which your heart can't pump enough blood to address your body's issues. The expression "heart failure" doesn't imply that your heart has stopped or is going to stop working. Nonetheless, heart disappointment is a genuine condition that requires medicinal care. If you have heart failure, you may tire easily and need to restrict your exercises. Chronic Heart Disease can lead to heart failure by debilitating the heart muscle over time.

 

  • Track 20-1Pathophisiology
  • Track 20-2Different types of Heart complications
  • Track 20-3Clinical Diagnostic method
  • Track 20-4Case Studies and Risk Factor
  • Track 20-5Management of Diabetes induced Heart complications

Diabetes case studies are the detailed report of an individual, group, occasion or public. The information is gathered from a diversity of places by various methods. The contextual investigation strategy incorporates spotting what happens to, or reconstructing ‘the case history’ of a single participant or group of individuals, i.e. the idiographic approach. Case study permits an investigator to investigate a topic in far more detailed and minute way.

Clinical cardiology is an exceptional spotlight on thinks about including investigation and organization of heart infections, for instance, electrophysiology, cardiovascular inserts, heart recovery, cardiovascular drug, cardiovascular surgery, and recognizable proof of cardiovascular hazard factors.

 

  • Track 21-1Ingredients for diabetes surgery
  • Track 21-2Pertinent medical history
  • Track 21-3Methodology
  • Track 21-4Medical History

The endocrine disorder is regularly very perplexing, including a blended picture of hyposecretion and hypersecretion due to the input components associated with the endocrine framework. For instance, most types of hyperthyroidism are related to an overabundance of thyroid hormone and a low level of thyroid animating hormone.

The anterior pituitary is especially sensitive to iron overloaded which upsets hormonal emission resulting in hypogonadism, short stature, acquired hypothyroidism, and hypoparathyroidism. Glucose intolerance and diabetes mellitus are additionally regular in thalassaemic patients.

 

  • Track 22-1Different types of Endocrine Complications
  • Track 22-2Endocrine Complications related to Diabetes
  • Track 22-3Pathophysiology
  • Track 22-4Endocrine complications and Risk Factors

 Diabetes can be diagnosed based on plasma and glucose criteria or A1C criteria. Early in disease diabetes shows fewer symptoms so blood tests are used to diagnose diabetes and pre-diabetes. Clinical diagnosis of diabetes includes taking blood at a health-care facility center or commercial diagnosis center and sending the sample to a lab for examination.

 

 To assure that, the test outcomes are accurate lab investigation of the blood is required. Glucose calculating device used in a health-care provider office, such as finger-stick gadgets, is not sufficiently exact for investigation but rather might be utilized as a fast pointer of high glucose. High blood glucose can make a terrible effect on the heart. Coronary heart disease, heart disappointment can be watched habitually in the diabetes individuals.

\r\n

\r\n  

\r\n

  • Track 23-1Clinical Diabetes
  • Track 23-2Cardiovascular Disorders
  • Track 23-3Diagnosis methods of Heart Disease
  • Track 23-4Prevention methods of Diabetes and Heart Disease

Microscopic organisms and inflammations in the gums may escape into the bloodstream and cause blockages in the blood vessels, which diminish blood flow to the heart. Individuals with diabetes, who have poor control of their blood glucose levels will probably develop dental health problems.

These dental issues in people will influence them by physically and financially. Intake a balanced diet, getting normal exercise and surrendering smoking propensity are advised to diminish the hazard regarding oral health problems.

 

  • Track 24-1Diabetes and Dental Disorders
  • Track 24-2Genetic Linkage of Diabetes and Dental disease
  • Track 24-3Gum problems
  • Track 24-4Management of Diabetes induces Gum problems
  • Track 24-5Prevention Strategy

Typical endocrine capacity is essential for cardiovascular prosperity. Disperses of the endocrine system, including hormone hyperfunction and hypofunction, adequately influence the cardiovascular framework. Likewise, we analyze the cardiovascular advantages of re-establishing ordinary endocrine capacity.

 

  • Track 25-1Investigation of disease transmission
  • Track 25-2Diagnostic techniques
  • Track 25-3Disease Management
  • Track 25-4Case Studies and Risk Factor

Numerous genetic polymorphism has been linked to the development of type 2 diabetes. These genetic mutations can interact with the environment and the other genes to increase the risk of diabetes and its associated disorders. Different studies suggest that the type 2 diabetes is caused by both hereditary and environmental factors. Not every person who conveys a genetic mutation will get diabetes

  • Track 26-1SNP in Diabetes, Obesity and Heart
  • Track 26-2Factors associated with Diabetes, Obesity and Heart
  • Track 26-3Case Studies of Genetic Linkage

Fortuitously, most skin conditions can be prevented or effectively treated if get diagnosed early. These incorporate with bacterial infections, fungal infections, and itching. Other skin problem happens mostly or only to people with diabetes

  • Track 27-1Signs and Symptoms
  • Track 27-2Risk Factors of Diabetic and Skin Problems
  • Track 27-3Treatments
  • Track 27-4Disease associated with Diabetic and Skin Problems

Diabetic Neuropathy is a neuropathic issue that is related to diabetes mellitus. These conditions are thought to come about because of diabetic microvascular damage including little veins that supply nerves (vasa nervorum) in addition to macrovascular conditions that can culminate in diabetic neuropathy.

Generally, normal conditions which might be related to diabetic neuropathy incorporate third nerve paralysis; mononeuropathy; mononeuropathy multiplex; diabetic amyotrophy; an excruciating polyneuropathy; autonomic neuropathy; and thoracoabdominal neuropathy. 

Diabetic retinopathy, otherwise called diabetic eye sickness, is a therapeutic condition in which damage occurs to the retina because of diabetes and is the leading cause of loss of vision. 

 

  • Track 28-1Signs and Symptoms
  • Track 28-2Risk Factors of Diabetic Neuropathy and Diabetic Retinopathy

Diabetic Hepatopathy Simple steatosis or non-alcoholic steatohepatitis are liver diseases associated with diabetes mellitus (DM). To identify scientific studies and to deepen the knowledge on DH, and to evaluate the prevalence of DH in the main published studies in medical literature. Only studies that evaluated the prevalence of DH were selected, summarizing and identifying the limitations of research from 1965 to date

  • Track 29-1Treatments
  • Track 29-2Disease associated with Diabetic Hepatopathy and Glycogenic Hepatopathy

Diabetes insipidus  is a condition characterized by large amounts of dilute urine and increased thirst. The amount of urine produced can be 20 liters per day. Central Diabetes Insipidus  is due to a lack of the hormone vasopressin i.e antidiuretic hormone. Dipsogenic Diabetes Insipidus is a result of excessive fluid intake due to damage to the hypothalamic thirst mechanism. This can be due to injury to the hypothalamus or pituitary gland or genetics.

Nephrogenic Diabetes Insipidus occurs when the kidneys do not respond properly to vasopressin.. It occurs more often in those with certain psychiatric disorders or on certain medications. Gestational Diabetes Insipidus occurs only during pregnancy. Treatment involves drinking sufficient fluids to prevent dehydration. Other treatments depend on the type. In central and gestational Diabetes insipidus , treatment is with desmopressin.

 

  • Track 30-1Nephrogenic
  • Track 30-2Dipsogenic
  • Track 30-3Gestational